4//SEC Filing
Hirsch David Brian 4
Accession 0001181431-09-054884
CIK 0001174940other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 4:44 PM ET
Size
18.8 KB
Accession
0001181431-09-054884
Insider Transaction Report
Form 4
ORAGENICS INCORNI
Hirsch David Brian
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (Right to Buy)
2009-12-01+1,000,000→ 1,000,000 totalExercise: $0.27Exp: 2019-12-01→ Common Stock (1,000,000 underlying) - Award
Employee Stock Option (Right to Buy)
2009-12-01+100,000→ 100,000 totalExercise: $0.27→ Common Stock (100,000 underlying) - Award
Employee Stock Option (Right to Buy)
2009-12-01+112,500→ 112,500 totalExercise: $0.27→ Common Stock (112,500 underlying) - Award
Employee Stock Option (Right to Buy)
2009-12-01+125,000→ 125,000 totalExercise: $0.27→ Common Stock (125,000 underlying)
Footnotes (5)
- [F1]Such stock option may be exercised as follows: one-third on the first anniversary of the date of grant (12/01/2010), with an additional one-third becoming exercisable on each of the following two anniversaries of the date of grant. Notwithstanding such time vesting, the options shall become immediately vested in full in the event of a change in control of the Company as specified in the stock option agreement between Mr. Hirsch and the Company.
- [F2]The options are included herein, notwithstanding that the exercisability of such option awards is subject to the achievement of certain Company performance targets.
- [F3]The options with respect to up to 112,500 shares of common stock shall become vested and exercisable by Mr. Hirsch upon the first calendar quarter in which the Company reports a Net Profit in a Form 10-Q Report or Form 10-K Report, as the case may be, that is publicly filed with the Securities and Exchange Commission ("SEC") under the Securities Exchange Act of 1934 as amended (the "Exchange Act"). These options expire and are void unless exercised on or before the earlier to occur of (i) December 1, 2019, or (ii) the time in which the Company ceases being obligated to file quarterly and annual reports with the SEC under the Exchange Act.
- [F4]The options with respect to up to 125,000 shares of common stock shall become vested and exercisable by Mr. Hirsch in tranches, on the last day of any three consecutive month period upon either (i) the shipment or invoicing of of a certain designated amount of units or boxes of consumer products during each of three consecutive months, or (ii) the shipment or invoicing of a designated amount of units or boxes of consumer products during any three consecutive month period. These options expire and are void unless they become vested and exercisable as follows: one-third on September 1, 2010, one-third on December 1, 2010, and one-third on March 1, 2010. To the extent any options become vested and exercisable (that have not expired in accordance with expiration schedule), they shall expire and are void unless exercised on or before December 1, 2019.
- [F5]The options with respect to up to 100,000 shares of common stock shall become vested and exercisable by Mr. Hirsch upon the occurrence of certain designated milestones related to scientific development of the Company technology's. The options expire and are void unless they become vested and exercisable on or before December 31, 2011. To the extent any of these options become vested and exercisable, they shall expire and be void unless exercised on or before December 1, 2019.
Issuer
ORAGENICS INC
CIK 0001174940
Entity typeother
Related Parties
1- filerCIK 0001439290
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 4:44 PM ET
- Size
- 18.8 KB